Eloxx Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Eloxx Pharmaceuticals | NT 10-K: Others
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Eloxx Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
Eloxx Pharmaceuticals | 8-K: Current report
Eloxx Pharmaceuticals | 8-K: Current report
No Data